Animal study · rats
BPC-157 limited isoprenaline-induced heart attack damage in rats
Checked against the paper Animal studyPublished by PepVault
The takeaway
This adds rat evidence that BPC-157 lessened drug-induced heart attack damage, but it has not been shown in people.
- Kind
- Animal study
- Studied in
- Rats
- Published
- 2022
- Journal
- Biomedicines
What they tested
The team tested whether BPC-157 could counter heart attacks, repeat heart attacks and early damage to many organs brought on by the drug isoprenaline in rats.
How the study was done
An animal study in rats given isoprenaline at 75 or 150 mg/kg under the skin, either once or twice 24 hours apart, with heart results checked at the end of the next 24 hours. BPC-157 was given into the belly cavity at 10 ng/kg or 10 µg/kg, either 30 min before or 5 min after isoprenaline, and was compared with and combined with L-NAME, a blocker of nitric oxide production, and L-arginine.

What they found
In rats, BPC-157 lowered all the heart damage markers measured: CK, CK-MB, LDH and cTnT (cardiac troponin T). Treated rats showed no visible infarcted area, meaning no patch of dead heart muscle, and less damage under the microscope. Their ECG showed no ST-T changes linked to poor blood flow, and their echocardiography (heart ultrasound) showed preserved pumping function of the left ventricle. At 30 min after isoprenaline, BPC-157 given 5 min after the drug lessened early damage in the brain, heart, lungs, liver, kidneys and gut, along with clotting and abnormal blood pressures in several vessels, and it lowered measures of oxidative stress.
What it doesn’t show
This was done in rats with heart damage brought on by a drug, so it is not a human result. Effects were followed only over short periods, up to about 24 hours after the last isoprenaline dose.
The paper
Barisic et al. Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats. Biomedicines. 2022.
The compound
More studies on BPC-157
- BPC-157: 10 of 12 women reported full interstitial cystitis reliefClinical trial · people · 2024
- BPC-157: 14 of 16 reported knee pain relief in a chart reviewObservational study · people · 2021
- BPC-157: non-significant tendon gains in rats; TB-500 did betterAnimal study · rats · 2026
- BPC-157 reduced leg muscle damage after ischemia-reperfusion in ratsAnimal study · rats · 2026
- BPC-157 closed duodenocolic fistulas in ratsAnimal study · rats · 2024
- BPC-157 reduced radiation liver injury in mice and rat liver cellsAnimal study · mice · 2022
- Every study on BPC-157
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.